ISPOR Europe 2025 Launches Patient-Centered Value Collaborations for Hospital Leaders Across the Region

11 November 2025

ISPOR Europe 2025, the premier European conference on Health Economics and Outcomes Research (HEOR), opened today, welcoming hospital administrators, procurement professionals, clinical leadership, and healthcare technology vendors from across the continent. The event is dedicated to the theme "Powering Value and Access Through Patient-Centered Collaboration," focusing sharply on current strategic priorities affecting the hospital sector, including partnership models, regulatory evolution, and regional implementation of cutting-edge healthcare management practices.

European hospitals face escalating pressures—from rising costs and staffing shortages to increasingly complex reimbursement and access frameworks. ISPOR’s flagship event responds by gathering global experts and local decision-makers for sessions, workshops, and interactive discussions designed to help organizations navigate this shifting landscape. Hospital executives, health economists, and policy makers are sharing actionable insights on building sustainable collaboration models that amplify patient input in technology assessment, pricing, and resource allocation. One key highlight is the focus on integrating patient voices into the Joint Clinical Assessment (JCA), which is increasingly central to EU Health Technology Assessment (HTA) systems. Detailed exploration of these methodologies equips hospital leaders with strategies to advocate for equitable reimbursement, optimal procurement, and improved patient outcomes.

The conference agenda also features dedicated tracks addressing digital transformation, real-world evidence (RWE) utilization, and application of artificial intelligence to healthcare operational workflows. Leading industry figures and academic experts present research on deploying electronic health records, cross-border interoperability solutions, and digital innovation to maximize operational efficiency and clinical performance in hospital settings. Leadership panels tackle practical topics such as leveraging flexible procurement to counteract medicine shortages, embracing market access adaptation to regulatory reforms, and harmonizing digital platforms for comprehensive inventory and supply chain resilience. Real-time case studies drive home the importance of embedding digital management for medication handling, infection control, and diagnostics deployment.

Hospital procurement professionals and clinical leaders attending ISPOR Europe gain exposure to the newest methods for evaluating cost-effectiveness, negotiating value-based contracts, and safeguarding access to breakthrough medicines and medical devices. The growing trend toward multi-stakeholder engagement—uniting payers, regulators, providers, and patient advocates—is examined as a catalyst for unlocking value and driving system-wide transformation. Sessions such as "Accelerating Patient Access to Innovations in Europe" provide actionable models for integrating patient-centric evaluation within diverse HTA environments, ensuring that hospitals remain agile in responding to regulatory and clinical demands.

In addition, sessions delve into the operationalization of AI for market access workflows, efficiency in early access programs (such as France’s evolving regulatory frameworks), and integrating global pricing policy lessons relevant to European hospitals facing budget constraints and competition for cutting-edge treatments. Discussions on harmonizing evidence requirements and digital infrastructure reveal the practical solutions hospitals can implement to optimize care pathways, improve decision support, and enhance safety and workflow reliability.

ISPOR Europe 2025 stands out as a key event for hospital executives seeking to benchmark best practices, network with policy shapers, and deploy new tools and collaborative models in their organizations. The conference’s emphasis on strategic hospital management, digital transformation, and patient-centered innovation will have lasting influence on procurement strategies, value-based care implementation, and regulatory compliance across Europe’s hospital sector.